C07K 5/0205
Containing the structure -nh-3-c-
Official title: {containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof}
C07K5/0205 (Containing the structure -nh-3-c-) appears on 432 US grants and 367 published applications in this corpus.
Search patents in C07K- Granted patents
- 432
- Published applications
- 367
- Assignees
- 226
- Inventors
- 1,182
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 5 | 0 |
| 1989 | 6 | 0 |
| 1990 | 4 | 0 |
| 1991 | 10 | 0 |
| 1992 | 8 | 0 |
| 1993 | 12 | 0 |
| 1994 | 5 | 0 |
| 1995 | 12 | 0 |
| 1996 | 12 | 0 |
| 1997 | 12 | 0 |
| 1998 | 25 | 0 |
| 1999 | 20 | 0 |
| 2000 | 22 | 0 |
| 2001 | 14 | 3 |
| 2002 | 13 | 24 |
| 2003 | 13 | 17 |
| 2004 | 7 | 17 |
| 2005 | 15 | 28 |
| 2006 | 17 | 19 |
| 2007 | 12 | 13 |
| 2008 | 17 | 13 |
| 2009 | 12 | 13 |
| 2010 | 15 | 10 |
| 2011 | 4 | 9 |
| 2012 | 7 | 4 |
| 2013 | 5 | 12 |
| 2014 | 9 | 16 |
| 2015 | 12 | 17 |
| 2016 | 13 | 20 |
| 2017 | 6 | 12 |
| 2018 | 7 | 20 |
| 2019 | 11 | 11 |
| 2020 | 12 | 17 |
| 2021 | 9 | 17 |
| 2022 | 7 | 10 |
| 2023 | 9 | 9 |
| 2024 | 10 | 20 |
| 2025 | 4 | 7 |
| 2026 | 5 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives12 May 2026US 12,622,944 B2Ambrx, Inc.
- Modified enzyme and method of producing imidazole dipeptide using same5 May 2026US 12,618,056 B2Ajinomoto Co., Inc.
- Bioorthogonal compositions28 Apr 2026US 12,611,461 B2Tambo, Inc.
- Derivatives of dolaproine-dolaisoleuine peptides28 Apr 2026US 12,612,429 B2Agensys, Inc.
- Compound comprising self-immolative group and ligand-drug conjugate comprising same17 Mar 2026US 12,576,156 B2Trioar, Inc.
- Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives17 Sep 2026US 2026/0273017 A1Ambrx, Inc.
- Novel linker compound and ligand-drug conjugate therefor27 Aug 2026US 2026/0248936 A1Trioar, Inc.
- Ptp1b/tc-ptp dual inhibitors and protein degraders20 Aug 2026US 2026/0240878 A1Purdue Research Foundation
- Linker-drug molecule and antibody drug conjugate, preparation method therefor and use thereof13 Aug 2026US 2026/0232825 A1
- Xten conjugate compositions and methods of making same16 Jul 2026US 2026/0199434 A1Amunix Pharmaceuticals, Inc.
Most cited
By later US patents
- Lysosomal enzyme-cleavable antitumor drug conjugates653US 6,214,345 B1Bristol-Myers Squibb Company · 2001
- Tumor inhibiting tetrapeptide bearing modified phenethyl amides449US 5,635,483 AArizona Board of Regents acting on behalf of Arizona State University · 1997
- Elucidation and synthesis of selected pentapeptides433US 5,780,588 AArizona Board of Regents · 1998
- Pentapeptide compounds and uses related thereto298US 6,884,869 B2Seattle Genetics, Inc. · 2005
- Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease256US 7,659,241 B2Seattle Genetics, Inc. · 2010